These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 32943371)
21. Non-Langerhans cell histiocytosis with isolated CNS involvement: an unusual variant of Erdheim-Chester disease. Conley A; Manjila S; Guan H; Guthikonda M; Kupsky WJ; Mittal S Neuropathology; 2010 Dec; 30(6):634-47. PubMed ID: 20337948 [TBL] [Abstract][Full Text] [Related]
22. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients. Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919 [TBL] [Abstract][Full Text] [Related]
23. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review]. Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585 [TBL] [Abstract][Full Text] [Related]
24. Neuroimaging features of CNS histiocytosis syndromes. Wang Y; Camelo-Piragua S; Abdullah A; Ibrahim M; Parmar HA Clin Imaging; 2020 Mar; 60(1):131-140. PubMed ID: 31874337 [TBL] [Abstract][Full Text] [Related]
26. The changing landscape of pediatric histiocytoses: Birth, life, and transdifferentiation of pediatric histiocytes. Auerbach A; Aguilera NS Semin Diagn Pathol; 2023 Nov; 40(6):420-428. PubMed ID: 37258365 [TBL] [Abstract][Full Text] [Related]
27. Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis. Erker C; Harker-Murray P; Talano JA Pediatr Clin North Am; 2017 Feb; 64(1):91-109. PubMed ID: 27894453 [TBL] [Abstract][Full Text] [Related]
28. Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis. Liu T; Cai HC; Cai H; Chen M; Zhang W; Li J; Zhou DB; Cao XX Orphanet J Rare Dis; 2022 Feb; 17(1):39. PubMed ID: 35130950 [TBL] [Abstract][Full Text] [Related]
29. [Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis]. Bösmüller H; Nann D; Horger M; Fend F Pathologe; 2015 Sep; 36(5):458-66. PubMed ID: 26305142 [TBL] [Abstract][Full Text] [Related]
30. Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib. Portegys J; Heidemeier A; Rosenwald A; Gernert M; Fröhlich M; Hueper S; Strunz PP; Rasche L; Schmalzing M RMD Open; 2023 Jan; 9(1):. PubMed ID: 36693681 [TBL] [Abstract][Full Text] [Related]
31. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease. Haroche J; Abla O Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774 [TBL] [Abstract][Full Text] [Related]
33. Saving orphans: BRAF targeting of histiocytosis. Heaney ML Blood; 2013 Feb; 121(9):1487-8. PubMed ID: 23449613 [TBL] [Abstract][Full Text] [Related]
34. [Erdheim-Chester disease: a non-Langerhans cell histiocytosis. A clinical-case and review of the literature]. Valentini D; Cappelli C; Mizzoni F; Noto C; Toscano D; Foco M; Trasimeni G Clin Ter; 2004 May; 155(5):205-8. PubMed ID: 15344569 [TBL] [Abstract][Full Text] [Related]
35. Histiocytosis and Neoplasms of Macrophage-Dendritic Cell Lineages: Multimodality Imaging with Emphasis on PET/CT. Huynh KN; Nguyen BD Radiographics; 2021; 41(2):576-594. PubMed ID: 33606566 [TBL] [Abstract][Full Text] [Related]
36. Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study. Diamond EL; Subbiah V; Lockhart AC; Blay JY; Puzanov I; Chau I; Raje NS; Wolf J; Erinjeri JP; Torrisi J; Lacouture M; Elez E; Martínez-Valle F; Durham B; Arcila ME; Ulaner G; Abdel-Wahab O; Pitcher B; Makrutzki M; Riehl T; Baselga J; Hyman DM JAMA Oncol; 2018 Mar; 4(3):384-388. PubMed ID: 29188284 [TBL] [Abstract][Full Text] [Related]
37. Ophthalmic histiocytic lesions (diseases of the L group): A multicenter clinicopathological study of 18 cases and review of literature. Alzahem T; Alkatan HM; Maktabi AM; Alsulaiman N; Cruz AAV Eur J Ophthalmol; 2023 Jan; 33(1):556-566. PubMed ID: 35816372 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults. Cao XX; Sun J; Li J; Zhong DR; Niu N; Duan MH; Liang ZY; Zhou DB Ann Hematol; 2016 Apr; 95(5):745-50. PubMed ID: 26858028 [TBL] [Abstract][Full Text] [Related]
39. [Histiocytic diseases in childhood and adolescence]. Vokuhl C; Oschlies I; Klapper W; Leuschner I Pathologe; 2015 Sep; 36(5):443-50. PubMed ID: 26292932 [TBL] [Abstract][Full Text] [Related]
40. Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAF Pieri V; Berzero G; Paterra R; Ferré L; Tomelleri A; Campochiaro C; Esposito F; Calimeri T; Cangi MG; Tenace NP; Ferreri AJM; Castellano A; Barbera M; Anzalone N; Gay LG; Bello L; Colecchia M; Ponzoni M; Finocchiaro G; Filippi M J Neurol; 2024 Jan; 271(1):575-579. PubMed ID: 37725109 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]